E-Labelling Guidelines for Medical Products
30 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is one potential benefit of digital labels?

  • Preservation of natural resources (correct)
  • Increase in paper consumption
  • Higher carbon footprint
  • Increased environmental impact
  • Digital labels contribute to an increase in carbon footprint.

    False (B)

    What impact would the elimination of paper consumption have on the environment?

    It would reduce environmental impact.

    Digital labels help to reduce carbon footprint and preserve __________ resources.

    <p>natural</p> Signup and view all the answers

    What qualities should statements about medicines possess?

    <p>Clear, concise, evidence-based, and relevant (D)</p> Signup and view all the answers

    Match the following effects with their outcomes related to digital labels:

    <p>Eliminate paper consumption = Preserve natural resources Reduce carbon footprint = Decrease environmental impact Enhance sustainability = Support eco-friendly practices</p> Signup and view all the answers

    Statements related to medicines should be kept stagnant and not updated once created.

    <p>False (B)</p> Signup and view all the answers

    Why is it important for statements about medicines to be evidence-based?

    <p>To ensure accuracy and reliability in healthcare information.</p> Signup and view all the answers

    Statements regarding medicines should be updated throughout their ______ as new data emerge.

    <p>lifecycle</p> Signup and view all the answers

    Match the following qualities with their descriptions:

    <p>Clear = Easily understood without confusion Concise = Free from unnecessary words Evidence-based = Backed by research and data Relevant = Applicable to the context of healthcare professionals</p> Signup and view all the answers

    What is a significant advantage of e-labels over conventional paper labels?

    <p>Easier updates for safety information (B)</p> Signup and view all the answers

    E-labels can be easily updated after being included in a product's package.

    <p>False (B)</p> Signup and view all the answers

    What types of formats can e-labels deliver personalized information in?

    <p>text, audio, or video formats</p> Signup and view all the answers

    E-labels can provide information in the patient's preferred __________.

    <p>language</p> Signup and view all the answers

    Match the following features with their descriptions:

    <p>E-labels = Allow faster updates for safety information Conventional paper labels = Cannot easily be updated once included Personalized information = Can be delivered in various formats User-friendly = Designed to accommodate the user's needs</p> Signup and view all the answers

    What may happen if the MAHs do not comply with the requirements?

    <p>Regulatory actions from EDA (B)</p> Signup and view all the answers

    Failure to adhere to the implementation plans can lead to the approval letter being canceled.

    <p>True (A)</p> Signup and view all the answers

    What specific action can be taken against shipments that lack paper leaflets?

    <p>Recall of shipments</p> Signup and view all the answers

    Failure to comply with any of the requirements can lead to __________ actions from the EDA.

    <p>regulatory</p> Signup and view all the answers

    Match the following consequences with their definitions:

    <p>Cancellation of approval letter = The disallowance of a product to be marketed Recall of shipments = The act of retrieving products that have been distributed Regulatory action = Official measures taken to enforce compliance Deviation from plans = An act of not following the established procedures</p> Signup and view all the answers

    What is the primary goal of the Central administration of Biological and Innovative products and Clinical Trials in EDA?

    <p>To establish an electronic product information service (D)</p> Signup and view all the answers

    Vaccine and monoclonal antibodies are included in the scope of the electronic product information service.

    <p>True (A)</p> Signup and view all the answers

    What does EPI stand for in the context of biological products?

    <p>Electronic Product Information</p> Signup and view all the answers

    The Central administration aims to provide an updated and officially approved electronic version of _____ information.

    <p>product</p> Signup and view all the answers

    Match the biological products with their descriptions:

    <p>Vaccine = A substance used to stimulate the production of antibodies Monoclonal antibodies = Antibodies that are made by identical immune cells Plasma derived medicinal products = Therapeutics made from human blood plasma Clinical Trials = Research studies to test the efficacy of a drug or treatment</p> Signup and view all the answers

    What document must an applicant provide when submitting a request for shared packs?

    <p>The URL generated by the company (D)</p> Signup and view all the answers

    Applicants are responsible for applying a QR code as approved by the EDA.

    <p>True (A)</p> Signup and view all the answers

    What is the responsibility of an applicant when there is an update to a product label?

    <p>Update the e-label immediately through the concerned units.</p> Signup and view all the answers

    Applicants can submit proposals for e-labelling in the registration dossier for new products with no change in the ______.

    <p>process</p> Signup and view all the answers

    Match the following actions with their responsibilities:

    <p>Submit request = Includes the URL Apply QR code = As approved by EDA Update e-label = Immediately after approval Propose e-labelling = No change in registration process</p> Signup and view all the answers

    Flashcards

    Clear Communication

    Information must be easily understood by healthcare professionals.

    Concise Information

    Messages should be brief and to the point for effective comprehension.

    Evidence-based Practices

    Healthcare information must rely on verified data and research.

    Relevance to Healthcare

    Content must directly apply to the practices of healthcare professionals.

    Signup and view all the flashcards

    Lifecycle Updates

    Information on medicines must be refreshed as new data and research become available.

    Signup and view all the flashcards

    E-Labels

    Electronic labels that provide up-to-date information on products.

    Signup and view all the flashcards

    Fast Information Sharing

    The ability to quickly disseminate updates and new information.

    Signup and view all the flashcards

    Personalized Patient Information

    Tailored health info considering individual medical conditions.

    Signup and view all the flashcards

    Multi-Format Delivery

    Information can be shared in text, audio, or video formats.

    Signup and view all the flashcards

    Language of Choice

    Providing information in the patient's preferred language.

    Signup and view all the flashcards

    Digital Labels

    Labels that are electronically delivered instead of printed, reducing paper usage.

    Signup and view all the flashcards

    Paper Consumption

    The amount of paper used for printing labels and documents.

    Signup and view all the flashcards

    Natural Resources Preservation

    Protecting resources like trees and water by using less paper.

    Signup and view all the flashcards

    Carbon Footprint Reduction

    Decreasing the total carbon emissions produced by paper usage and transportation.

    Signup and view all the flashcards

    Environmental Impact

    The effect that our actions, like paper usage, have on the earth's ecosystems.

    Signup and view all the flashcards

    EPI

    Electronic Product Information providing updates and approvals.

    Signup and view all the flashcards

    Biological Products

    Medicinal products derived from biological sources, like vaccines.

    Signup and view all the flashcards

    Clinical Trials

    Research studies testing biomedical or behavioral interventions.

    Signup and view all the flashcards

    Monoclonal Antibodies

    Lab-made molecules that can mimic the immune system's ability.

    Signup and view all the flashcards

    Registration Administration

    Process of officially listing and approving biological products.

    Signup and view all the flashcards

    Regulatory Actions

    Consequences enforced by EDA for non-compliance with requirements.

    Signup and view all the flashcards

    Cancellation of Approval

    Revocation of previously granted permission to market a product.

    Signup and view all the flashcards

    Recall of Shipments

    Withdrawal of products from the market due to violations like missing leaflets.

    Signup and view all the flashcards

    MAHs Responsibilities

    Marketing Authorization Holders must adhere to regulatory requirements.

    Signup and view all the flashcards

    Paper Leaflets Requirement

    Mandate to include informational leaflets in product packaging for compliance.

    Signup and view all the flashcards

    QR Code Application

    Applicants must use the QR code approved by EDA.

    Signup and view all the flashcards

    E-Labelling Proposal

    Applicants can propose e-labelling for new products during registration.

    Signup and view all the flashcards

    Label Update Approval

    Any updates to a label must be approved before implementation.

    Signup and view all the flashcards

    Immediate E-Label Update

    E-labels must be updated quickly once label changes are approved.

    Signup and view all the flashcards

    Registration Dossier

    The file containing all information for product registration including e-labelling.

    Signup and view all the flashcards

    Study Notes

    Guideline on E-Labelling of Medical Leaflets of Medicinal and Biological Products for Human Use

    • This guideline details e-labelling of medicinal and biological products for human use.
    • The document was issued on 01/05/2024.
    • This guideline applies to E-Labelling of medical leaflets for medicinal and biological products for human use.
    • The legal basis for the document includes a technical committee decision dated 8/9/2022 and 16/11/2023, approval from the Legal Counsel of the Egyptian Drug Authority, and other regulating rules and guidance issued by the EDA.
    • The document defines applicant, Electronic Product Information (ePI), Summary of Product Characteristics (SmPC), Patient Information Leaflet (PIL), and the Expanded Programme on Immunization (EPI).
    • Important abbreviations used in the document include EDA, MAH, QR code, URL, HCP, PDF, PAC, HL7, and FHIR.
    • Electronic Labelling (E-labelling) is a digital alternative to physical labelling for disseminating updated product information and facilitating communication among manufacturers, healthcare providers, and patients.
    • E-labelling in Egypt uses a machine-readable QR code on product packaging.
    • Paper leaflets have limitations like poor readability, difficulty in updating, and challenges with product recalls.
    • E-labeling offers benefits such as easier access to information, enhanced safety and use instructions, improved sharing of information, accessibility for users with disabilities, reduced paper consumption, and better understanding for patients and healthcare professionals.
    • The E-labelling project implementation involves three stages with gradual removal of paper leaflets (from eligible products).
    • Stage 1 involved using both paper and electronic formats linked via QR codes.
    • Stage 2 is focused on expanding QR codes to more product types and incorporating user feedback.
    • Stage 3 aims for complete elimination of paper leaflets and enhanced data interoperability.
    • The implementation of e-labelling is voluntary for certain products like hospital-use products under HCP supervision (e.g., intravenous drugs, immunosuppressants, oncologic products).
    • The E-labeling guideline includes specific criteria for selecting pharmaceutical products eligible for stage 2 e-labelling (products exclusively supplied to healthcare institutions, prescribed by physicians and administered inside the institutions).
    • This guideline specifies the required formats of e-labels (QR code on product packaging with a PDF format) for display optimization on electronic devices.
    • It outlines roles and responsibilities for the scientific file examination unit and applicants, including how they submit a request for an e-label, the acceptance procedures and timeframes.

    Annexes

    • The document includes various annexes with further details on medicinal products flowcharts, e-label formatting templates, EDA fees for services, and application forms.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers the guidelines for e-labelling of medicinal and biological products for human use, as outlined in the document issued on 01/05/2024. It includes definitions of key terms such as ePI, SmPC, and PIL, as well as important abbreviations relevant to the context. Test your knowledge on the digital alternatives to physical labelling and the legal frameworks guiding these practices.

    More Like This

    Use Quizgecko on...
    Browser
    Browser